Published in Mol Pharmacol on January 28, 2009
Chloride channels: often enigmatic, rarely predictable. Annu Rev Physiol (2010) 1.94
The sticky issue of neurosteroids and GABA(A) receptors. Trends Neurosci (2010) 1.21
Activation and modulation of concatemeric GABA-A receptors expressed in human embryonic kidney cells. Mol Pharmacol (2009) 0.95
Characteristics of concatemeric GABA(A) receptors containing α4/δ subunits expressed in Xenopus oocytes. Br J Pharmacol (2012) 0.92
Molecular mechanisms of antiseizure drug activity at GABAA receptors. Seizure (2013) 0.92
Two etomidate sites in α1β2γ2 γ-aminobutyric acid type A receptors contribute equally and noncooperatively to modulation of channel gating. Anesthesiology (2012) 0.90
Kinetic and structural determinants for GABA-A receptor potentiation by neuroactive steroids. Curr Neuropharmacol (2010) 0.90
Mapping General Anesthetic Sites in Heteromeric γ-Aminobutyric Acid Type A Receptors Reveals a Potential For Targeting Receptor Subtypes. Anesth Analg (2016) 0.90
A synthetic 18-norsteroid distinguishes between two neuroactive steroid binding sites on GABAA receptors. J Pharmacol Exp Ther (2010) 0.87
Occupation of either site for the neurosteroid allopregnanolone potentiates the opening of the GABAA receptor induced from either transmitter binding site. Mol Pharmacol (2011) 0.86
Neurosteroid analogues. 17. Inverted binding orientations of androsterone enantiomers at the steroid potentiation site on γ-aminobutyric acid type A receptors. J Med Chem (2012) 0.83
A neurosteroid potentiation site can be moved among GABAA receptor subunits. J Physiol (2012) 0.80
Use of concatemers of ligand-gated ion channel subunits to study mechanisms of steroid potentiation. Anesthesiology (2011) 0.79
Agonist-specific conformational changes in the α1-γ2 subunit interface of the GABA A receptor. Mol Pharmacol (2012) 0.76
Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (1989) 60.30
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature (2006) 4.33
Forced subunit assembly in alpha1beta2gamma2 GABAA receptors. Insight into the absolute arrangement. J Biol Chem (2002) 2.44
Subunit arrangement of gamma-aminobutyric acid type A receptors. J Biol Chem (2001) 1.97
Neurosteroid access to the GABAA receptor. J Neurosci (2005) 1.95
Modulation of GABA(A) receptor channel gating by pentobarbital. J Physiol (2001) 1.74
Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations. Mol Pharmacol (1994) 1.57
Neuroactive steroids have multiple actions to potentiate GABAA receptors. J Physiol (2004) 1.47
Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids. Mol Pharmacol (2008) 1.46
Individual properties of the two functional agonist sites in GABA(A) receptors. J Neurosci (2003) 1.42
Long-range, small magnitude nonadditivity of mutational effects in proteins. Biochemistry (1995) 1.41
Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABAA receptor. Mol Pharmacol (2007) 1.33
Chloride channel expression with the tandem construct of alpha 6-beta 2 GABAA receptor subunit requires a monomeric subunit of alpha 6 or gamma 2. J Biol Chem (1995) 1.08
New insight into long-range nonadditivity within protein double-mutant cycles. Proteins (2008) 1.06
The cholinergic antagonist alpha-bungarotoxin also binds and blocks a subset of GABA receptors. Proc Natl Acad Sci U S A (2006) 1.02
Neuroactive steroids and human recombinant rho1 GABAC receptors. J Pharmacol Exp Ther (2007) 1.00
Neurosteroid access to the GABAA receptor. J Neurosci (2005) 1.95
Mechanisms of neurosteroid interactions with GABA(A) receptors. Pharmacol Ther (2007) 1.60
Neuroactive steroids have multiple actions to potentiate GABAA receptors. J Physiol (2004) 1.47
Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids. Mol Pharmacol (2008) 1.46
Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors. J Physiol (2003) 1.38
Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABAA receptor. Mol Pharmacol (2007) 1.33
Dual potentiating and inhibitory actions of a benz[e]indene neurosteroid analog on recombinant alpha1beta2gamma2 GABAA receptors. Mol Pharmacol (2006) 1.31
3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J Neurosci (2002) 1.18
Activation of GABA(A) receptors containing the alpha4 subunit by GABA and pentobarbital. J Physiol (2004) 1.18
Rare missense variants in CHRNB4 are associated with reduced risk of nicotine dependence. Hum Mol Genet (2011) 1.08
Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA-A receptor potentiation. J Physiol (2007) 1.07
Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor. Mol Pharmacol (2012) 1.05
Anticonvulsant and anesthetic effects of a fluorescent neurosteroid analog activated by visible light. Nat Neurosci (2007) 1.03
The cholinergic antagonist alpha-bungarotoxin also binds and blocks a subset of GABA receptors. Proc Natl Acad Sci U S A (2006) 1.02
Neuroactive steroids and human recombinant rho1 GABAC receptors. J Pharmacol Exp Ther (2007) 1.00
Activation and block of mouse muscle-type nicotinic receptors by tetraethylammonium. J Physiol (2003) 1.00
Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site. J Neurosci (2005) 0.96
Activation and modulation of concatemeric GABA-A receptors expressed in human embryonic kidney cells. Mol Pharmacol (2009) 0.95
Functional characterization of the α5(Asn398) variant associated with risk for nicotine dependence in the α3β4α5 nicotinic receptor. Mol Pharmacol (2011) 0.95
Cytisine binds with similar affinity to nicotinic alpha4beta2 receptors on the cell surface and in homogenates. Brain Res (2003) 0.94
A portable site: a binding element for 17β-estradiol can be placed on any subunit of a nicotinic α4β2 receptor. J Neurosci (2011) 0.94
Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors. J Biol Chem (2008) 0.93
Role of the agonist binding site in up-regulation of neuronal nicotinic alpha4beta2 receptors. Mol Pharmacol (2006) 0.93
Hydrogen bonding between the 17beta-substituent of a neurosteroid and the GABA(A) receptor is not obligatory for channel potentiation. Br J Pharmacol (2009) 0.93
Ethanol modulates the interaction of the endogenous neurosteroid allopregnanolone with the alpha1beta2gamma2L GABAA receptor. Mol Pharmacol (2006) 0.92
Enantiomers of neuroactive steroids support a specific interaction with the GABA-C receptor as the mechanism of steroid action. Mol Pharmacol (2006) 0.92
Characteristics of concatemeric GABA(A) receptors containing α4/δ subunits expressed in Xenopus oocytes. Br J Pharmacol (2012) 0.92
The influence of the membrane on neurosteroid actions at GABA(A) receptors. Psychoneuroendocrinology (2009) 0.91
Kinetic and structural determinants for GABA-A receptor potentiation by neuroactive steroids. Curr Neuropharmacol (2010) 0.90
Low doses of ethanol and a neuroactive steroid positively interact to modulate rat GABA(A) receptor function. J Physiol (2003) 0.89
The nicotinic α5 subunit can replace either an acetylcholine-binding or nonbinding subunit in the α4β2* neuronal nicotinic receptor. Mol Pharmacol (2013) 0.88
Kinetic analysis of voltage-dependent potentiation and block of the glycine alpha 3 receptor by a neuroactive steroid analogue. J Physiol (2009) 0.88
A synthetic 18-norsteroid distinguishes between two neuroactive steroid binding sites on GABAA receptors. J Pharmacol Exp Ther (2010) 0.87
Occupation of either site for the neurosteroid allopregnanolone potentiates the opening of the GABAA receptor induced from either transmitter binding site. Mol Pharmacol (2011) 0.86
Photoaffinity labeling the agonist binding domain of alpha4beta4 and alpha4beta2 neuronal nicotinic acetylcholine receptors with [(125)I]epibatidine and 5[(125)I]A-85380. Biochim Biophys Acta (2009) 0.85
Activation and block of the adult muscle-type nicotinic receptor by physostigmine: single-channel studies. Mol Pharmacol (2008) 0.85
Cis-regulatory variants affect CHRNA5 mRNA expression in populations of African and European ancestry. PLoS One (2013) 0.85
Common polymorphisms in FMO1 are associated with nicotine dependence. Pharmacogenet Genomics (2011) 0.84
Site-specific fluorescence reveals distinct structural changes induced in the human rho 1 GABA receptor by inhibitory neurosteroids. Mol Pharmacol (2010) 0.84
Pharmacology of structural changes at the GABA(A) receptor transmitter binding site. Br J Pharmacol (2011) 0.83
The benzodiazepine diazepam potentiates responses of α1β2γ2L γ-aminobutyric acid type A receptors activated by either γ-aminobutyric acid or allosteric agonists. Anesthesiology (2013) 0.82
A neurosteroid potentiation site can be moved among GABAA receptor subunits. J Physiol (2012) 0.80
Structural studies of the actions of anesthetic drugs on the γ-aminobutyric acid type A receptor. Anesthesiology (2011) 0.80
Energetic contributions to channel gating of residues in the muscle nicotinic receptor β1 subunit. PLoS One (2013) 0.78
Agonist-specific conformational changes in the α1-γ2 subunit interface of the GABA A receptor. Mol Pharmacol (2012) 0.76
Pharmacology: Unready for action. Nature (2008) 0.75
Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol. Curr Neuropharmacol (2016) 0.75
Inhibition of muscle acetylcholine receptors by nondepolarizing drugs: humans are not unique. Anesthesiology (2010) 0.75